Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

(2012) Brad H. Rovin et al.   ARTHRITIS AND RHEUMATISM

The landscape after LUNAR: Rituximab's crater-filled path

(2012) Liz Lightstone   ARTHRITIS AND RHEUMATISM

Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits

(2011) T. Jonsdottir et al.   ANNALS OF THE RHEUMATIC DISEASES

B cell biomarkers of rituximab responses in systemic lupus erythematosus

(2011) Edward M. Vital et al.   ARTHRITIS AND RHEUMATISM

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis

(2011) N. Mansfield et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen

(2011) A. N. Ezeonyeji et al.   RHEUMATOLOGY

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Lupus nephritis: where are we now?

(2010) Liz Lightstone   CURRENT OPINION IN RHEUMATOLOGY

Practice pattern variation in oral glucocorticoid therapy after the induction of response in proliferative lupus nephritis

(2010) M. Walsh et al.   LUPUS

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts

(2010) T. Jonsdottir et al.   RHEUMATOLOGY

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

(2009) F A Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

(2009) G. B. Appel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis

(2009) Jai Radhakrishnan et al.   KIDNEY INTERNATIONAL

Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years

(2009) JD Posalski et al.   LUPUS

Beyond immunosuppression – challenges in the clinical management of lupus nephritis

(2009) S Masood et al.   LUPUS

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Efficacy of Biologicals in the Treatment of Rheumatoid Arthritis

(2008) S.P. Venkateshan et al.   PHARMACOLOGY